Regulating the regulator: negative regulation of Cbl ubiquitin ligases

被引:78
作者
Ryan, PE
Davies, GC
Nau, MM
Lipkowitz, S
机构
[1] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] George Washington Univ, Inst Biomed Sci, Washington, DC 20037 USA
关键词
D O I
10.1016/j.tibs.2005.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cbl proteins are regulators of signal transduction through many pathways and, consequently, regulate cell function and development. They are ubiquitin ligases that ubiquitinate and target many signaling molecules for degradation. The Cbl proteins themselves are regulated by an increasingly complex network of interactions that fine-tune the effects that Cbl proteins have on signaling. The negative regulation of Cbl protein function can occur via cis-acting structural elements that prevent inappropriate ubiquitin ligase activity, degradation of the Cbl proteins, inhibition without degradation owing to interaction with other signaling proteins, deubiquitination of Cbl substrates, and regulation of assembly of the endosomal ESCRT-I complex. Defects in the regulatory mechanisms that control Cbl function are implicated in the development of immunological and malignant diseases.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 102 条
[21]   Cbl signaling networks in the regulation of cell function [J].
Dikic, I ;
Szymkiewicz, I ;
Soubeyran, P .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (09) :1805-1827
[22]   The Cbl family and other ubiquitin ligases: Destructive forces in control of antigen receptor signaling [J].
Duan, L ;
Reddi, AL ;
Ghosh, A ;
Dimri, M ;
Band, H .
IMMUNITY, 2004, 21 (01) :7-17
[23]   EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-ALPHA - DIFFERENTIAL INTRACELLULAR ROUTING AND PROCESSING OF LIGAND-RECEPTOR COMPLEXES [J].
EBNER, R ;
DERYNCK, R .
CELL REGULATION, 1991, 2 (08) :599-612
[24]   The genome of the social amoeba Dictyostelium discoideum [J].
Eichinger, L ;
Pachebat, JA ;
Glöckner, G ;
Rajandream, MA ;
Sucgang, R ;
Berriman, M ;
Song, J ;
Olsen, R ;
Szafranski, K ;
Xu, Q ;
Tunggal, B ;
Kummerfeld, S ;
Madera, M ;
Konfortov, BA ;
Rivero, F ;
Bankier, AT ;
Lehmann, R ;
Hamlin, N ;
Davies, R ;
Gaudet, P ;
Fey, P ;
Pilcher, K ;
Chen, G ;
Saunders, D ;
Sodergren, E ;
Davis, P ;
Kerhornou, A ;
Nie, X ;
Hall, N ;
Anjard, C ;
Hemphill, L ;
Bason, N ;
Farbrother, P ;
Desany, B ;
Just, E ;
Morio, T ;
Rost, R ;
Churcher, C ;
Cooper, J ;
Haydock, S ;
van Driessche, N ;
Cronin, A ;
Goodhead, I ;
Muzny, D ;
Mourier, T ;
Pain, A ;
Lu, M ;
Harper, D ;
Lindsay, R ;
Hauser, H .
NATURE, 2005, 435 (7038) :43-57
[25]   Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex [J].
Ettenberg, SA ;
Magnifico, A ;
Cuello, M ;
Nau, MM ;
Rubinstein, YR ;
Yarden, Y ;
Weissman, AM ;
Lipkowitz, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27677-27684
[26]   TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin [J].
Feshchenko, EA ;
Smirnova, EV ;
Swaminathan, G ;
Teckchandani, AM ;
Agrawal, R ;
Band, H ;
Zhang, XL ;
Annan, RS ;
Carr, SA ;
Tsygankov, AY .
ONCOGENE, 2004, 23 (27) :4690-4706
[27]   Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function [J].
Fong, CW ;
Leong, HF ;
Wong, ESM ;
Lim, J ;
Yusoff, P ;
Guy, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :33456-33464
[28]   Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters [J].
Fritz, G ;
Brachetti, C ;
Bahlmann, F ;
Schmidt, M ;
Kaina, B .
BRITISH JOURNAL OF CANCER, 2002, 87 (06) :635-644
[29]  
Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO
[30]  
2-B